- 1 BAZE: Boston-Based Personalized Nutrition Startup, Baze, Announces FDA Approval For Blood-Based Testing Kits
- 2 CLENE NANOMEDICINE: Announces Formal Acceptance of CNM-Au8 for HEALEY ALS Platform Trial as Center Receives FDA Approval to Proceed
- 3 MOST SACRED HEART OF JESUS CARDIOLOGY: Newly Minted FDA Commissioner Dr. Stephen Hahn Receives Minneapolis FDA Affidavit From Dr. Nalini Rajamannan Regarding FDA Design Control Study Using a Non-Exempt Medical Device
- 4 BIOHAVEN PHARMACEUTICALS: Biohaven's Verdiperstat Receives FDA May Proceed Letter To Initiate Trial In Amyotrophic Lateral Sclerosis Conducted By The Healey Center For ALS At Mass General
- 5 CELULARITY: Announces FDA Clearance of Landmark IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy
Get the latest business news and updates - delivered right to your inbox
By signing up you agree to receive email newsletters or alerts from FDA Reporter. You can unsubscribe at any time.